Sometimes the right tool for the right job appears almost out of nowhere. That was certainly the case for [Jonathan] who came ...

CHICAGO, March 03, 2026 (GLOBE NEWSWIRE) -- COUR Pharma, a clinical-stage biotechnology company developing first-in-class, antigen-specific immune tolerance therapies for autoimmune diseases, today ...

The team behind Big Red’s Barn is planning to launch its Capy Hour Cafe, a reservation-only, Brazilian inspired, capybara integrated cafe on March 31. The cafe will be inside the Big Red’s Barn ...

Coeur Mining (CDE) surged 258% over the past year as silver broke through $80 and joined the U.S. Critical Minerals list. We expect Coeur Mining to release their earnings tonight at about 4:30 p.m. ET ...

CHICAGO (AP) — CHICAGO (AP) — Coeur Mining Inc. (CDE) on Wednesday reported fourth-quarter net income of $215 million. On a per-share basis, the Chicago-based company said it had profit of 29 cents.

PALOS HILLS, Ill. (WLS) -- Palos Hills police shot and killed an armed man, while responding to a domestic disturbance call Sunday, officials said Tuesday. Palos Hills police officers responded just ...

Silver and gold prices are falling. Coeur stock is following them down, but earnings this year will still be much higher than last year. Shares of the gold miner (which also mines silver) fell 6.1% ...

The merger, expected to close in the first half of 2026 pending final approval from regulators and the Supreme Court of British Columbia, will result in the formation of a combined company, in which ...

All hotels have been independently reviewed by our expert writers, who are usually hosted on a complimentary basis. We will earn a commission if you book via the links below, but this never affects ...

Should you have feedback on this article, please complete the fields below. Please indicate if your feedback is in the form of a letter to the editor that you wish to have published. If so, please be ...

Paper defines the mechanism by which COUR Nanoparticles induce antigen-specific immune tolerance CHICAGO, Jan. 28, 2026 (GLOBE NEWSWIRE) -- COUR Pharma, a clinical-stage biotechnology company ...